A novel characterized multi-drug-resistant Pseudocitrobacter sp. isolated from a patient colonized while admitted to a tertiary teaching hospital

  15 February 2024

A novel bacterial species was isolated from a patient’s rectal swab, revealing 99.7% 16s rRNA identity to Pseudocitrobacter corydidari, an Asian cockroach-associated species. The isolate had the highest average nucleotide identity (ANI) at 0.9562, suggesting resistance to carbapenems, β-lactams, sulfonamides, fluoroquinolones, macrolides, aminoglycosides, and cephalosporins. The patient was colonized, not infected, and did not require antimicrobial treatment. Genome data for this new species have been submitted to GENBANK using the proposed nomenclature Pseudocitrobacter limerickensis.

Author(s): S.A. Kelly et al
Healthy Patients  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed